Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease or ALS, is a devastating, rapidly advancing disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. But researchers have identified a new target for slowing the deterioration of physical function for which the disease is so well known.